Skip to main content

Advertisement

SpringerLink
Log in

Neurogenic Bladder in Pediatrics and Adolescents

  • Neurogenic Bladder (F Daneshgari, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Neurogenic bladder in the pediatric population underwent an evolution in treatment patterns during the 20th century. This paradigm change began with an evolving understanding of the health risks children with this condition face and the variable pathophysiology resulting in their condition. Introduction of clean intermittent catheterization and anticholinergic medication revolutionized care of these young patients. Advances in our knowledge of bladder pathology, and novel techniques to improve lower urinary tract function have made a variety of treatments available to patients. Although some similarities exist between adult and pediatric neurogenic bladder, the pediatric patient provides unique challenges with growth and development and helping children gain independence. Presented is a review of the treatment options and an algorithm to support the two main goals of treatment: protection of the upper urinary tract from renal function deterioration and development of social continence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Thompson DNP. Spinal dysraphic anomalies; classification, presentation and management. Paediatr Child Health. 2010;20(9):397–403.

    Article  Google Scholar 

  2. Abrahamsson K, Olsson I, Sillén U. Urodynamic findings in children with myelomeningocele after untethering of the spinal cord. J Urol. 2007;177(1):331–4.

    Article  PubMed  Google Scholar 

  3. Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol. 1999;162:1068–71.

    Article  PubMed  CAS  Google Scholar 

  4. Generao SE, Dall’Era JP, Stone AR, Kurzrock EA. Spinal cord injury in children: long-term urodynamic and urological outcomes. J Urol. 2004;172(3):1092–4.

    Article  PubMed  Google Scholar 

  5. Bauer SB. Neurogenic bladder: etiology and assessment. Pediatr Nephrol. 2008;23(4):541–51.

    Article  PubMed  Google Scholar 

  6. Silveri M, Salsano L, Pierro MM, Mosiello G, Capitanucci ML, De Gennaro M. Pediatric spinal cord injury: approach for urological rehabilitation and treatment. J Pediatr Urol. 2006;2(1):10–5.

    Article  PubMed  CAS  Google Scholar 

  7. Tanaka ST, Stone AR, Kurzrock EA. Transverse myelitis in children: long-term urological outcomes. J Urol. 2006;175(5):1865–8.

    Article  PubMed  Google Scholar 

  8. Decter RM, Bauer SB, Khoshbin S, et al. Urodynamic assessment of children with cerebral palsy. J Urol. 1987;138(4 Pt 2):1110–2.

    PubMed  CAS  Google Scholar 

  9. Morrisroe SN, O’Connor RC, Nanigian DK, Kurzrock EA, Stone AR. Vesicostomy revisited: the best treatment for the hostile bladder in myelodysplastic children? BJU Int. 2005;96(3):397–400.

    Article  PubMed  Google Scholar 

  10. Lapides J, Diokno AC, Silber SM, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 1972;107:458–61.

    PubMed  CAS  Google Scholar 

  11. Anagnostopoulos D, Joannides E, Kotsianos K. The urological management of patients with myelodysplasia. Pediatr Surg Int. 1988;3:347–50.

    Article  Google Scholar 

  12. Holzbeierlein J, Pope JC, Adams MC, Bruner J, Tylipan N, Brock JW. The urodynamic profile of myelodysplasia in childhood with spinal closure during gestation. J Urol. 2000;164:1336–9.

    Article  PubMed  CAS  Google Scholar 

  13. Edelstein RA, Bauer SB, Kelly M, et al. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol. 1995;154:1500–4.

    Article  PubMed  CAS  Google Scholar 

  14. Klose A, Sackett C, Mesrobian H. Management of children with myelodysplasia: urological alternatives. J Urol. 1990;144:1446–9.

    PubMed  CAS  Google Scholar 

  15. Tanaka H, Kazizaki H, Kobayashi S, Shibata T, Ameda K, Koyanagi T. The relevance of urethral resistance in children with myelodysplasia: its impact on upper urinary tract deterioration and the outcome of conservative management. J Urol. 1999;161:929–32.

    Article  PubMed  CAS  Google Scholar 

  16. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol. 1981;126:205–9.

    PubMed  CAS  Google Scholar 

  17. Palmer LS, Richards I, Kaplan W. Age related bladder capacity and bladder capacity growth in children with myelomeningocele. J Urol. 1997;158:1261–4.

    Article  PubMed  CAS  Google Scholar 

  18. Painter KA, Vates TS, Bukowski TP, et al. Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia. J Urol. 1996;156:1459–62.

    Article  PubMed  CAS  Google Scholar 

  19. Palmer LS, Zebold K, Firlit CF, Kaplan WE. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population. J Urol. 1997;157:638–40.

    Article  PubMed  CAS  Google Scholar 

  20. Altaweel W, Jednack R, Bilodeau C, Corcos J. Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol. 2006;175(3):1102–5.

    Article  PubMed  CAS  Google Scholar 

  21. Franco I. Overactive bladder in children. Part 2: management. J Urol. 2007;178(3):769–74.

    Article  PubMed  Google Scholar 

  22. Pascali MP, Mosiello G, Boldrini R, Salsano ML, Castelli E, De Gennaro M. Effects of botulinum toxin Type A in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections. J Urol. 2011;185(6):2552–7.

    Article  PubMed  CAS  Google Scholar 

  23. Hoebeke P, De Caestecker K, Vande Walle J, et al. The effect of botulinum-A toxin in Incontinent children with therapy resistant overactive detrusor. J Urol. 2006;176(1):328–31.

    Article  PubMed  CAS  Google Scholar 

  24. Schulte-Baukloh H, Michael T, Stürzebecher B, Knispel HH. Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol. 2003;44(1):139–43.

    Article  PubMed  CAS  Google Scholar 

  25. • De Gennaro M, Capitanucci ML, Mosiello G, Zaccara A. Current state of nerve stimulation technique for lower urinary tract dysfunction in children. J Urol. 2011;185(5):1571–7. This study gives an excellent review of data behind nerve stimulation in children, and future directions in research.

    Article  PubMed  Google Scholar 

  26. • Clark C, Ngo T, Comiter CV, Anderson R, Kennedy W. Sacral nerve stimulator revision due to somatic growth. J Urol. 2011;186(4):1576–80. This study provides an example of the data needed in the pediatric population regarding nerve stimulation. Though it is a very small sample size, this helps build knowledge and efficacy data on the use of sacral stimulation.

    Article  PubMed  Google Scholar 

  27. Quek ML, Ginsberg DA. Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol. 2003;169:195–8.

    Article  PubMed  Google Scholar 

  28. Medel R, Ruarte AC, Herrera M, Castera R, Podesta ML. Urinary continence outcome after augmentation ileocystoplasty as a single surgical procedure in patients with myelodysplasia. J Urol. 2002;168:1849–52.

    Article  PubMed  Google Scholar 

  29. DeFoor W, Minevich E, Reddy P, et al. Bladder calculi after augmentation cystoplasty: risk factors and prevention strategies. J Urol. 2004;172(5):1964–6.

    Article  PubMed  Google Scholar 

  30. Leyland JW, Masters JG. Conservative management of an intraperitoneal rupture of an augmentation cystoplasty and continent urinary diversion in an adult. J Urol. 2003;170(2):524.

    Article  PubMed  Google Scholar 

  31. Soergel TM, Cain MP, Misseri R, Gardner TA, Koch MO, Rink RC. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004;172(4):1649–52.

    Article  PubMed  Google Scholar 

  32. • Kokorowski PJ, Routh JC, Borer JG, Estrada CR, Bauer SB, Nelson CP. Screening for malignancy after augmentation cystoplasty in children with spina bifida: a decision analysis. J Urol. 2011;186(4):1437–43. This study gives a good, realistic approach to screening for patients after augmentation. It provides support that patients should be counseled preoperatively about a small risk of malignancy.

    Article  PubMed  Google Scholar 

  33. Sundaram CP, Reinberg Y, Aliabadi HA. Failure to obtain durable results with collagen implantation in children with urinary incontinence. J Urol. 1997;157:2306–7.

    Article  PubMed  CAS  Google Scholar 

  34. Austin PF, Westney OL, Leng WW, McGuire EJ, Ritchey M. Advantages of rectus fascial slings for uinary incontinence in children with neuropathic bladder. J Urol. 2001;165:2369–72.

    Article  PubMed  CAS  Google Scholar 

  35. Castera R, Podesta ML, Ruarte AC, Herrera M, Medel R. 10-year experience with artificial urinary sphincter in children and adolescents. J Urol. 2001;165:2373–6.

    Article  PubMed  CAS  Google Scholar 

  36. Hajlvassilou CA. A review of the complications and results of implantation of the AMS artificial urinary sphincter. Eur Urol. 1999;35(1):36–44.

    Article  Google Scholar 

  37. Holmes NM, Kogan BA, Baskin LS. Placement of artificial urinary sphincter in children and simultaneous gastrocystoplasty. J Urol. 2001;165:2366–8.

    Article  PubMed  CAS  Google Scholar 

  38. Catto J, Natarajan V, Tophill P. Simultaneous augmentation cystoplasty is associated with earlier rather than increased artificial urinary sphincter infection. J Urol. 2005;173(4):1237–41.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. University Hospitals Urology Institute, 11100 Euclid Avenue, Cleveland, OH, 44106, USA

    Peter P. Stuhldreher, Edward E. Cherullo & Robert Kohut

Authors
  1. Peter P. Stuhldreher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward E. Cherullo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Kohut
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edward E. Cherullo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stuhldreher, P.P., Cherullo, E.E. & Kohut, R. Neurogenic Bladder in Pediatrics and Adolescents. Curr Bladder Dysfunct Rep 7, 75–82 (2012). https://doi.org/10.1007/s11884-012-0131-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-012-0131-1

Keywords

Search

Navigation